Extended interval dosing with ocrelizumab in multiple sclerosis.
Article in Multiple Sclerosis Journal (April 2024)
The most recent citing publications are shown below. View all 162 publications that cite this research output on Dimensions.
Article in Multiple Sclerosis Journal (April 2024)
Article in Heliyon (March 2024)
Book chapter (February 2024)